Jared Baeten

Summary

Publications

  1. ncbi request reprint Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA, USA Department of Medicine, University of Washington, Seattle, WA, USA Department of Epidemiology, University of Washington, Seattle, WA, USA Electronic address
    Lancet Infect Dis 14:1055-64. 2014
  2. pmc Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    J Acquir Immune Defic Syndr 63:S122-9. 2013
  3. pmc Use of antiretrovirals for HIV prevention: what do we know and what don't we know?
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 10:142-51. 2013
  4. pmc Oral antiretroviral chemoprophylaxis: current status
    Jared Baeten
    Department of Global Health, University of Washington, Seattle, Washington, USA
    Curr Opin HIV AIDS 7:514-9. 2012
  5. pmc Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis
    Jared Baeten
    Department of Global Health, University of Washington, USA
    Annu Rev Med 64:219-32. 2013
  6. pmc Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    N Engl J Med 367:399-410. 2012
  7. pmc Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 39:21-4. 2012
  8. pmc Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples
    Jared M Baeten
    University of Washington, WA, USA
    AIDS 24:737-44. 2010
  9. ncbi request reprint A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships
    Renee Heffron
    Department of Epidemiology, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 37:621-8. 2010
  10. pmc Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 4:e5272. 2009

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA, USA Department of Medicine, University of Washington, Seattle, WA, USA Department of Epidemiology, University of Washington, Seattle, WA, USA Electronic address
    Lancet Infect Dis 14:1055-64. 2014
    ..We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP...
  2. pmc Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    J Acquir Immune Defic Syndr 63:S122-9. 2013
    ..At this important transition point-from demonstration of efficacy in clinical trials to thinking about implementation and effectiveness-this review addresses where we have been and where we are going with PrEP for HIV prevention...
  3. pmc Use of antiretrovirals for HIV prevention: what do we know and what don't we know?
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 10:142-51. 2013
    ....
  4. pmc Oral antiretroviral chemoprophylaxis: current status
    Jared Baeten
    Department of Global Health, University of Washington, Seattle, Washington, USA
    Curr Opin HIV AIDS 7:514-9. 2012
    ..Preexposure prophylaxis (PrEP), in which HIV uninfected persons with ongoing HIV risk use oral antiretroviral medications as chemoprophylaxis against sexual HIV acquisition, is a promising new HIV prevention strategy...
  5. pmc Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis
    Jared Baeten
    Department of Global Health, University of Washington, USA
    Annu Rev Med 64:219-32. 2013
    ..Next steps in the field include rigorous evaluation of uptake and adherence to PrEP in implementation settings and research into next-generation PrEP agents with longer half-life and less user dependence...
  6. pmc Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    N Engl J Med 367:399-410. 2012
    ..Antiretroviral preexposure prophylaxis is a promising approach for preventing human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations...
  7. pmc Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial
    Jared M Baeten
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 39:21-4. 2012
    ..1 vs. 6.0 days) and cessation of herpes simplex virus shedding (HR = 1.88, P = 0.008; mean, 3.0 vs. 5.0 days) compared with placebo, similar to results of studies in high-income countries (ClinicalTrials.gov registration NCT00808405)...
  8. pmc Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples
    Jared M Baeten
    University of Washington, WA, USA
    AIDS 24:737-44. 2010
    ....
  9. ncbi request reprint A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships
    Renee Heffron
    Department of Epidemiology, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 37:621-8. 2010
    ..Few studies have explored contraceptive use in HIV-1 serodiscordant couples, a population at high risk for HIV-1 transmission...
  10. pmc Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study
    Jairam R Lingappa
    Department of Global Health, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 4:e5272. 2009
    ..We describe the baseline characteristics of this cohort...